参考文献

［1］王娅丹.结核分枝杆菌PPE蛋白家族免疫原性初探［D］.杭州：浙江理工大学，2012.

［2］吴雪琼，吴长有.结核病免疫学［M］.北京:人民卫生出版社，2016.

［3］张福红，魏铁垒，刘丽莹，等.肺结核患者治疗中免疫球蛋白E及血清细胞因子检测的临床意义［J］.中华医院感染学杂志，2016，26（16）:3648-3650.

［4］高阳，宋其生，周洁，等.GeneXpert MTB/RIF 在新发活动性肺结核诊断及对利福平耐药快速检测中的应用价值［J］.结核病与肺部健康杂志，2018，7（1）:29-32.

［5］李峤珂，吴雪琼，阳幼荣，等.CFP10/ESAT6融合蛋白-ELISPOT方法的建立及其在结核分枝杆菌感染诊断中的应用价值［J］.中国人兽共患病学报，2010，26（6）:551-554.

［6］梁艳，吴雪琼，王兰，等.应用酶联免疫斑点试验检测入伍新兵结核潜伏感染［J］.中国感染控制杂志，2011，10（4）:244-247.

［7］吴雪琼.提高结核抗体试剂质量、加强临床筛选评估研究［J］.中国防痨杂志，2018，40（1）:5-8.

［8］CHANCELLOR A，GADOLA S D，MANSOUR S.The versatility of the CD1 lipid antigen presentation pathway［J］.Immunology，2018，154（2）:196-203.

［9］JAMES C A，YU K K，GILLERON M，et al.CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis［J］.Cell Chem Biol，2018，25（4）:392-402.

［10］VAN R I，IWANY S K，FODRAN P，et al.CD1b-mycolic acid tetramers demonstrate T-cell fine specificity for mycobacterial lipid tails［J］.Eur J Immunol，2017，47（9）:1525-1534.

［11］WORLD HEALTH ORGANIZATION.Global Tuberculosis Report 2020［R/OL］.2020.https://www.who.int/publications/i/item/global-tuberculosis-report-2020.

［12］CAO S H，CHEN Y Q，SUN Y，et al.Screening of Serum Biomarkers for Distinguishing between Latent and Active Tuberculosis Using Proteome Microarray［J］.Biomedical & Environmental Sciences Bes，2018，31（7）:515.

［13］PENN B H ，NETTER Z，JOHNSON J R，et al.An Mtb-Human Protein-Protein Interaction Map Identifies a Switch between Host Antiviral and Antibacterial Responses［J］.Mol Cell，2018，71（4）:637-648.

［14］CHOUDHARY A，PATEL D，HONNEN W，et al.Characterization of the Antigenic Heterogeneity of Lipoarabinomannan，the Major Surface Glycolipid of Mycobacterium tuberculosis，and Complexity of Antibody Specificities toward This Antigen［J］.Journal of Immunology，2018，200（9）:3053.

［15］SCHAIBLE U E，LINNEMANN L，REDINGER N，et al.Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity［J］.Front Immunol，2017（8）:1755.

［16］COPPOLA M，ARROYO L，MEIJGAARDEN K E，et al.Differences in IgG responses against infection phase related Mycobacterium tuberculosis（Mtb）specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression［J］.Tuberculosis（Edinb），2017（106）:25-32.

［17］MOGUCHE A O，MUSVOSVI M，PENN-NICHOLSON A，et al.Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis［J］.Cell Host Microbe，2017，21（6）:695-706.

［18］MANNA M P，ORLANDO V，LI D P，et al.Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease［J］.PLoS One，2018，13（3）:e0192664.

［19］PRADOS-ROSALES R，CARRENO L，CHENG T，et al.Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine［J］.PLoS Pathog，2017，13（3）:e1006250.

［20］BAI X J，WANG D F，LIU Y P，et al.Novel epitopes identified from Mycobacterium tuberculosis antigen Rv2629 induces cytotoxic T lymphocyte response［J］.Immunology Letters，2018（203）:21-28.

［21］GONG W，LIANG Y，WU X.The current status，challenges，and future developments of new tuberculosis vaccines［J］.Hum Vaccin Immunother，2018，14（7）:1697-1716.

［22］WARSINSKE H C，PIENAAR E，LINDERMAN J J，ET AL .Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model［J］.Front Immunol，2017，20（8）:1843.

［23］TRAN T H，KRISHNAN S，AMIJI M M.MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects［J］.PLoS One，2016，11（5）:e0152024.

［24］LOU J，WANG Y，ZHANG Z，et al.MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3［J］.Exp Cell Res，2017，358（2）:120-128.

［25］ABDALLA A E，LAMBERT N，DUAN X，et al.Interleukin-10 Family and Tuberculosis:An Old Story Renewed［J］.Int J Biol Sci，2016，12（6）:710-717.

［26］LOWE D M，DEMARET J，BANGANI N，et al.Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood［J］.Front Immunol，2018（9）:903.

［27］AGRAWAL S，PARKASH O，PALANIAPPAN A N，et al.Efficacy of T Regulatory Cells，Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response［J］.Front Immunol，2018（9）:157.

［28］BIAN Y，SHANG S，SIDDIQUI S，et al.MHCⅠb molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8 ⁺ T cells and contributes to protection against infection［J］.PLoS Pathog，2017，13（5）:e1006384.

［29］YANG J D，MOTT D，SUTIWISESAK R，et al.Mycobacterium tuberculosis-specific CD4 ⁺ and CD8 ⁺ T cells differ in their capacity to recognize infected macrophages［J］.PLoS Pathog，2018，14（5）:e1007060.

［30］BRIGHENTI S，JOOSTEN S A.Friends and foes of tuberculosis:modulation of protective immunity［J］.J Intern Med，2018（10）:1111. r7bG/fasf00UCRQGJzX9PTdOUK4pK0098E+4D0vxbmg2hQVRhDkAM7DQVjA2G49/